Skip to main content

Terminal deoxynucleotidyl transferase negative T-cell lymphoblastic lymphoma in aleukemic patient

Abstract

Precursor lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL) is a malignant neoplasm of precursor lymphocytes of T- or B-cell phenotype. We describe the unusual features of an ALL/LBL in an adolescent man in whom the disease presented with involvement of lymph nodes, but without bone marrow and peripheral blood involvement. Immunohistochemical studies revealed that the tumor cells were positive for CD3, CD34 class II, CD10, CD79a and CD99 but negative for TdT. Even though TdT was negative, he received ALL-therapy and is now in remission.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

  1. 1.

    Brunning RD, Borowitz M, Matutes E, et al. Precursor T lymphoblastic leukaemia/lymphoblastic lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardima JW, editors. World Health Organization classification of tumors: tumors of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p. 115–7.

    Google Scholar 

  2. 2.

    Hoelzer D, Gokbuget N, Digel W, et al. Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood. 2002;99:4379–85.

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Knowles DM. Lymphoblastic lymphoma. In: Knowles DM, editor. Neoplastic hematopathology. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 915–51.

    Google Scholar 

  4. 4.

    Soslow RA, Bhargava V, Warnke RA. MIC2, TdT, bcl–2, and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities. Hum Pathol. 1997;28:1158–65.

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    Marie JP, Haiat S, Legrand O. More intensive chemotherapy for young adults with ALL? Leuk Res. 2007;31(S2):S45–S46.

    Article  Google Scholar 

  6. 6.

    Lewis RE, Cruse JM, Sanders CM, Webb RN, et al. The immunophenotype of pre-TALL/LBL revised. Exp Mol Pathol. 2006;81:162–5.

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Suzumiya J, Ohshima K, Kikuchi M, Takeshita M, Akamatsu M, Tashiro K. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections: a useful method for the diagnosis of lymphoblastic lymphoma. J Pathol. 1997;182:86–91.

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Faber J, Kantarjian H, Roberts MW, Keating M, Freireich E, Albitar M. Terminal deoxynucleotidyl transferase–negative acute lymphoblastic leukemia. Arch Pathol Lab Med. 2000;124:92–7.

    CAS  PubMed  Google Scholar 

  9. 9.

    Kaleem Z, Crawford E, Pathan MH, et al. Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data. Arch Pathol Lab Med. 2003;127:42–8.

    PubMed  Google Scholar 

  10. 10.

    Reiter A, Schrappe M, Ludwig WD, et al. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood. 2000;95:416–21.

    CAS  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Marin Nola.

About this article

Cite this article

Brčić, I., Labar, B., Perić-Balja, M. et al. Terminal deoxynucleotidyl transferase negative T-cell lymphoblastic lymphoma in aleukemic patient. Int J Hematol 88, 189–191 (2008). https://doi.org/10.1007/s12185-008-0101-8

Download citation

Keywords

  • T-cell lymphoblastic lymphoma
  • TdT negative